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Abstract 
Background:  Increased left ventricular (LV) mass in children with chronic renal 
insufficiency (CRI) might represent an adaptive mechanism to compensate for 
increased workload. We hypothesize that in pre-dialysis CRI children, values of 
LV mass exceed compensatory value for individual cardiac load. Methods:  
Complete anthropometrics, biochemical profile and echocardiograms were 
obtained in 33 children with pre-dialysis CRI (age 1-23 yrs, mean 12.2±5.0 yrs; 
22 males) and 33 age- and gender-matched healthy controls. LV dimensions and 
wall thicknesses were measured from the M-mode, LV volume and long-axis 
dimension from the 2-D, blood pressure from 24-hour ambulatory recordings.  
Endocardial shortening, ejection fraction, LV mass, LV mass index, relative wall 
thickness, circumferential wall stress, and excess of LV mass (as ratio of  
observed LV mass to value predicted from body size, gender, and cardiac 
workload) were analyzed.  Results: CRI patients showed higher values of indexed 
LV chamber diameter and LV mass index, resulting in significantly higher 
prevalence of LVH (36.3 vs 9%; all p<0.05). In addition CRI patients showed 
lower LV ejection fraction, lower midwall fractional shortening and lower stress-
corected midwall shortening. The ratio of excess of LV mass was significantly 
greater in CRI patients than in normal controls (126±19 vs 103±13%; p<0.001). 
Conclusions: In CRI children values of LV mass are higher than those needed to 
sustain individual cardiac load compared to normal controls, a condition 
associated with LVH and reduced systolic performance.  
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INTRODUCTION  
Chronic renal insufficiency (CRI) is associated with the development of 
cardiac remodelling, premature cardiomyopathy (1, 2, 3, 4) and increased 
cardiovascular morbidity and mortality.  In adult patients with longstanding CRI 
undergoing dialysis, left ventricular (LV) hypertrophy is common and LV systolic 
function is often reduced (5). LV hypertrophy is present in more than 30% of 
patients in the early phases of CRI (6-8) and has been considered to be an 
adaptation to increased cardiac load (9, 10). Both concentric and eccentric LVH 
are seen in children with mild to moderate chronic renal failure (8,11), consistent 
with combined pressure and volume overload present in this condition.  Recent 
data on CRI children undergoing dialysis indicate that despite normal LV 
chamber function at rest, LV functional reserve during exercise is often decreased 
(11).  We have recently reported depressed resting LV midwall function and 
contractility, despite normal ejection fraction, in children with mild CRI and 
concentric LV geometry (12). We have suggested that the combination of 
concentric LV geometry and midwall dysfunction might represent a cardiac 
phenotype at higher risk of developing overt cardiovascular disease in children, 
consistent to what previously reported for adults (13). We have also demonstrated  
that the combination of concentric geometry with combined systolic and diastolic 
dysfunction features a cardiovascular phenotype characterized by levels of LV 
mass that are greater than predicted by individual body size and cardiac workload, 
a condition called excess of, or inappropriate LV mass (14). This excess of LV 
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mass is also associated with high cardiovascular risk independent of the presence 
of clear-cut LVH (15-17).  
Also in children with mild to moderate CRI, we found a combination of  
LV concentric geometry and systolic dysfunction at the midwall level (12), but 
there is no information on whether this phenotype  also correspond to excessive 
levels of LV mass, similar to what has been found in adults. Accordingly, in the 
present study we tested the hypothesis that the LV response is excessive in 
children with mild-to-moderate CRI, referred to individual body size and cardiac 
workload, and that, similar to adult populations, the excess of LV mass is 
associated with LV concentric geometry and dysfunction. 
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 METHODS 
Patients and control subjects 
Thirty-three children with established CRI from the Nephrology Unit of 
Bambino Gesù Children’s Hospital and a group of 33 sex and gender-matched 
healthy, non-obese children were enrolled in the study. Patients and controls 
underwent complete echocardiographic examination with simultaneous office 
blood pressure (BP) measurement.  Ambulatory blood pressure monitoring 
(ABPM) and biochemical assessments were obtained in CRI patients.  Data from 
a series of 130 normal children from previous studies (8, 18) were also analyzed 
to generate normal gradients of echocardiographic variables with age. The study 
protocol was designed in adherence to the declaration of Helsinki and approved 
by the Bambino Gesù Children’s Hospital Ethical Committee. Written informed 
consent was obtained from all parents and informed consent or assent from the 
patients when appropriate. 
BP Monitoring 
ABPM was performed only in CRI patients with a Spacelabs 90207 
automatic cuff-oscillometric device (Issaquah, WA). The cuff size was adjusted to 
the individual upper arm circumference. ABPM measurements were performed 
according to previously described standardized protocol (19). ABPM 
measurements were performed every 15 minutes during daytime and every 20-30 
minutes at night. All ABPM profiles were analyzed centrally. ABPM profiles 
were divided into daytime (8:00 a.m. to 8:00 p.m.) and nighttime periods (12:00 
p.m. to 6:00 a.m.). Mean values of 24-h, systolic, and diastolic BP were calculated 
 6 
and compared with reference data from healthy children (20) and presented as 
standard deviations from normal mean. Office BP measurements were obtained in 
patients and controls at the time of echocardiography after sitting for 5 min in a 
relaxed position, using oscillometric devices. 
Laboratory assessments  
A full biochemical profile was obtained only in CRI patients using 
standard laboratory techniques. In addition, serum and urinary sodium, creatinine, 
C-reactive protein (CRP, ultrasensitive assay), intact parathyroid hormone 
(Immulite Intact PTH, Medical Systems, Los Angeles) were measured. GFR was 
estimated from serum creatinine and height using the pediatric equations of 
Schwartz et al (21). 
Echocardiography 
Echocardiograms were performed in all participants using commercially 
available machines and standardized  procedures and recorded onto videotapes. 
Videotapes were shipped to the Echocardiography Laboratory of the Department 
of Clinical and Experimental Medicine “Federico II” University of Naples, Italy, 
for quality control and off-line reading. Echocardiograms were digitally acquired 
and electronically read using specifically designed work stations (MediMatic 
S.r.l., Genoa, Italy) according to standard procedures as previously reported (8). 
Measurements were made from either parasternal short-axis M-mode or 
parasternal long-axis two-dimensional images accordingly to the 
recommendations of the American Society of Echocardiography (22,23).  
Echocardiographic derived variables 
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LV mass was obtained according to a necropsy validated formula (24, 25) 
and normalized for height in meters to the allometric power of 2.7 (LVMI), to 
account for differences in body growth (26). LV hypertrophy (H) was defined 
when LVMI was greater than 38 g/m2.7, as previously reported (8). To evaluate 
the concentricity of LV geometry, myocardial thickness (posterior wall + septum) 
was divided by LV minor axis (diameter) to generate a relative wall thickness 
(RWT).  LV diastolic diameter was normalized by height. 
Stroke work was estimated by systolic blood pressure times stroke volume, 
calculated by the Teichholz formula (Teichoolz, AJC) and converted to 
grammeters/beat by multipluing by 0.014 (27). To establish whether the LVM 
was consistent with the increase in cardiac workload we calculated the individual 
predicted ideal value of LVM (LVMp) using the following equation generated in 
a reference normotensive, normal-weight population of children and adolescents 
(27) by stroke work, gender (male gender=1, female gender=2) and height in 
meters to the 2.7 power: 
LVMp= 1.59 + 17.81 x height 2.7+ 0.36 x stroke work - 3.88 x gender. 
The value of LVM measured from echocardiograms was divided by LVMp and 
expressed as % of predicted value (Δ%LVM). Values of Δ%LVM >95th percentile 
of reference population  (138%) were considered inappropriately high, indicating 
clear-cut excess of LVM relative to the value that would compensate and sustain 
the individual cardiac workload. 
End-systolic wall stress was estimated using a cylindrical model as previously 
reported (28)  
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where SBP is systolic pressure in mmHg, LVIDs is end-sistolic diameter in cm, 
PWTs is end-diastolic posterior wall thickness in cm. 
LV systolic function was determined by linear measures of shortening of LV 
minor axis both at the endocardial level (endocardial shortening [eS]) and at the 
midwall level (mS) (29-30). To account for the effect of myocardial afterload and 
for the demonstrated influence of age on the stress/shortening relations, both eS 
and mS were also expressed as the ratio between the observed values and the 
values predicted from individual  age and circumferential end-systolic wall stress 
(σ), using equations developed in a 4-to-17 year-old reference normal population 
of children and adolescents (31):  
eS = 90.13-24.89*log10[σ]-0.32 [years] 
mS = 30.78-3.98*log10[σ]-0.26 [years] 
.    
 LV diastolic function was assessed by transmitral pulsed Doppler, 
recorded in apical 4-chamber view according to standard procedures. Peak early 
(E) and late, or atrial (A), velocities were recorded and their ratio calculated.      
 
Statistical Analysis 
Statistical analyses was performed using SPSS 15.0.0 (SPSS Inc., Chicago, 
Illinois) software. Data are presented as mean±SD for continuous variables and as 
proportions for categorical variables. Chi-square statistics were used to determine 
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differences for categorical variables (with Monte Carlo method to compute exact 
two-tailed alpha value, when appropriate). One-way analysis of variance and 
analysis of variance were used to compare continuous variables both in cases and 
controls and in subgroup-analysis, always including controls. When needed, 
Ryan-Einot-Gabriel-Welsch F post-hoc test was used, or main effects were 
compared by Sidak’s adjustment of p value. The p values were shown for post-
hoc tests. Two-tailed p<0.05 was considered statistically significant. 
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RESULTS 
Patient characteristics 
The baseline clinical characteristics of patients and control subjects are given in 
Table 1 and 2. Among the 33 CRI patients, 15 (45.5%) were CKD class II (i.e. 
GFR 60-89 mL/min/1.73 m2), 3 (9%) class III (GFR 30-59 mL/min/1.73 m2) and 
15 (45.5%) class IV (GFR 15-29 mL/min/1.73 m2). The underlying renal diseases 
were renal hypo/dysplasia in 63%, other congenital or hereditary disease in 30% 
and glomerulopathies in 7%. CRI patients and controls showed similar values of 
BMI,  casual systolic/diastolic blood pressure and heart rate (all p=NS). 24-h BP 
in CRI patients was 0.6 SDS relative to reference populations (20). 
 
Cardiac Geometry and Function (table 2). 
CRI patients showed higher values of indexed LV chamber diameter 
(3.12±0.28 vs 2.90±0.27 cm/m) and LV mass index (35.9±11.2 vs 27.7±7.2), 
resulting in markedly higher prevalence of LVH. Relative wall thickness tended to 
be greater in CRI patients than in normals, but the difference did not achieve 
statistical significance (table 2). CRI patients also exhibited lower endocardial and 
midwall shortening than normal controls, only partially consistent with 
significantly increased end-systolic stress. In fact, stress-corrected midwall 
shortening was also significantly lower in CRI patients than in normal controls, 
indicating reduced myocardial contractility (Table 2).  Transmitral Doppler 
velocities and their ratio did not show differences between groups (table 2). 
Inappropriute LV mass. 
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Although stroke work tended to be greater in CRI patients, it was not 
statistically distinguishable from normal controls (table 2 ). Nevertheless, for the 
given workload and body size the amount of observed/predicted LV mass in CRI 
patients was largely exceeding the needs imposed by workload. Figure 1 shows 
the distribution of observed/predicted LV mass in controls and in CRI patients, 
using the 95 percentile of the normal distribution. Ten CRI patients (30%) fell 
over the 95th percentile of the normal distribution. Table 3 shows comparison 
between CRI  patients with or without inappropriate LV mass. Inappropriate LV 
mass was associated with concentric LV geometry and substantially reduced 
midwall shortening and stress-corrected midwall shortening, without differences 
in diastolic parameters. 
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DISCUSSION  
 This study presents the first evidence that the reported high LV mass in 
children with CRI is not matched with consistent cardiac workload. Similar to 
adults (14) this excess of LV mass is associated with left ventricle concentric 
geometry and with substantial fall of systolic function (endocardial shortening and 
midwall shortening (32)), but preservation of LV performance (stroke work). The 
fall in systolic function is not related to the increased myocardial afterload (end-
systolic stress), which is in fact reduced when LV mass is inappropriate, while it 
is substantially associated with a depressed wall mechanics indicating reduced 
myocardial contractility. These findings substantially parallel findings in adults 
(14), and suggest that CRI-related cardiac modifications occur independently of 
the age of exposition to the disease. 
 Also, interestingly, the excess of LV mass and the tendency to concentric 
LV geometry not completely offset myocardial afterload that appears to identical  
to normals confirming findings in adults where normal-low end-systolic stress 
was associated with a high-risk cardiovascular phenotype   
 Our findings also indicate differences of CRI from other conditions 
altering LV geometry in children. For example, infants with coarctation of the 
aorta develop concentric LVH before surgical repair.  In many patients some 
degree of LV hypertrophy persists even after adequate surgical repair.  In these 
children, however, LV systolic function and contractility, evaluated with different 
methods are usually increased (33-34). Although more recent data suggest that 
hyperdynamic function might originate from artifacts (35) , contractility is at least 
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normal in these patients with concentric hypertrophy, differently from what is 
found in children with CRI. Unfortunately, there is no information on the 
appropriateness of LV mass in other conditions of increased loading conditions in 
children.   
Moreover, severe LV hypertrophy and abnormal LV geometry are 
relatively prevalent in young patients with essential hypertension (36) with LV 
regional systolic function not showing  a difference according to the LV 
geometric pattern (37). 
  Pathophysiologic differences might account for the different phenotypes 
found in aortic coartation, hypertension and CRI, including age of exposure of 
myocardium to increase in loading conditions and non-hemodynamic factors 
(38). In aortic coartation, loading conditions are already abnormal at the birth and 
hypertrophyc process begins to take place at a time when cardiomyocytes still 
replicate, whereas in both hypertension  and CRI  the abnormality is delayed. In 
addition, and perhaps even more important, in aortic coartation the kidneys are 
not exposed to high blood pressure.  
Taken together our findings suggests that the development of LV mass in 
children with CRI might not be entirely due to needs to compensate hemodynamic 
load, but also to other non-hemodynamic factors affect LV growth, possibly 
related with kidney disease.     
We know that the adrenergic overdrive exerts a number of adverse effects 
on the cardiovascular system, by favoring the genesis of cardiac hypertrophy, 
vascular hypertrophy, arterial remodeling and endothelial dysfunction (39)  
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Furthermore, the renin-angiotensin system (RAS) and inflammation may 
play a decisive role in hypertensive end organ damage (EOD) including left 
ventricular (LV) hypertrophy and vascular remodeling. It seems to be the tissue 
RAS, rather the circulating RAS and inflammatory factors, that contributed to 
hypertensive cardiovascular hypertrophy (40,41) 
Also pregnancy is associated with physiological cardiac hypertrophy, but 
with a progressive decline in LV contractility through the 2nd and 3rd trimesters.  
There is rapid reversal of hypertrophy in the postpartum period while recovery of 
cardiac function is delayed, possibly related to postpartum upregulation of JNK 
(42). 
The possible implications of our findings can be surrogated from findings 
in adults. Increasing levels of excess LV mass significantly increase risk for 
cardiovascular morbidity and mortality in hypertensive adults (13) and portend a 
high risk of congestive heart failure in general population, independently of 
prevalent and incident myocardial infarction (43). Although we cannot prove the 
same prognostic effect in children with CRI, there are evident similarity between 
adults and children. 
This study is not designed as a prospective survey and we cannot derive 
prognostic conclusions. However, the emerging phenotype of children with excess 
LV mass is very similar to what is reported in adults, with a cluster of adverse 
cardiovascular modifications including concentric LV geometry, and systolic 
dysfunction (14). These children might require very close cardiovascular 
monitoring. 
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Table 1. Anthropometric and blood pressure characteristics of 33 patients with CRI and 33 healthy controls. 
 
Values are mean ± SD; CKD, chronic kindney disease; NA, not applicable. 
  Patients Controls  
Variable Units 
mean±SD 
median (range)
count (%) n 
mean±SD 
median (range) 
count (%) n p 
Gender male 22 (67) 33 22 (67) 33 ns 
Age years 12.2±5.0 33 11.6±5.0 33 ns 
Weight Kg 43.2±21.4 33 42.0±18.1 33 ns 
Height cm 143±26 33 145±25 33 ns 
Weight SDS 0.45±1.47 33 0.66±1.31 33 ns 
Height SDS -0.40±1.53 33 0.4±1.2 33 <0.05 
BMI SDS 0.61±1.3 33 0.97±1.6 33 ns 
HR b/min 75±15 33 78±12 33 ns 
SBP mmHg 108±15 33 103±13 33 ns 
DBP mmHg 60±16 33 56±9 33 ns 
SBP SDS 0.17±1.32 33 -0.24±1.32 33 ns 
DBP SDS -0.20±1.49 33 -0.46±1.04 33 ns 
24-h BP SDS 0.60±1.27 24 N/A  N/A 
Duration of CRI  years 12±5 33 N/A  N/A 
GFR ml/min/1.73 m2 46 (7-100) 33 N/A  N/A 
Serum creatinine mg/dl 2 (1-7) 33 N/A  N/A 
Serum CRP mg/L 0.3±0.5 27 N/A  N/A 
Serum PTH pmol/L 88.2±87.3 26 N/A  N/A 
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Table 2. LV geometry and systolic function in 33 CRI patients and 33 healthy controls. 
  Patients Controls  
Variable Units 
mean±SD 
median (range)
count (%) n 
mean±SD 
median (range) 
count (%) n p 
LVM/height 2.7 g/m2.7 35.9± 11.3 33 27.7± 7.3 33 <0.05 
LVH % 36.3 33 9 33 <0.05 
RWT  0.30±0.05 33 0.29±0.04 33 ns 
eS % 31.7± 3.8 33 35.5±6.1 33 <0.05 
mS % 17.7±1.9 33 19.6±2.8 33 <0.05 
cESS g /cm2 154± 34 33 136.4± 32 33 <0.05 
σ-corrected mS % 93.7±12.3 33 101.5±13.3 33 <0.02 
LVEDD/height cm/m 3.12±0.28 33 2.90±0.27 33 <0.002 
Stroke work gmtr/beat 86.9±39.9 33 76.63±28.13 33 ns 
Obs/pred LVM % 126±27 33 103±21 33 <0.001 
E peak cm/sec 102±20 30 102±14 17 ns 
A peak cm/sec 56±15 30 56±12 17 ns 
E/A ratio  1,92±0,57 30 1,90±0,39 17 ns 
DTE msec 140±26 30 130±20 17 ns 
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Table 3. Appropriateness of LV mass  in 33 CRI patients 
  Inappropriate LVM pts Appropriate LVM pts  
Variable Units 
mean±SD 
median (range)
count (%) n 
mean±SD 
median (range) 
count (%) n p 
LVM/height 2.7 g/m2.7 48.9±10.3 10 30.3±5.6 23 <0.001 
LVH % 90 10 13 23 <0.001 
RWT  0.34±0.04 10 0.29±0.04 23 <0.001 
eS % 32±5 10 31.5±3.3 23 ns 
mS % 16.8±2 10 18±1.7 23 ns 
σ-corrected mS % 87±9 10 99±12 23 <0.001 
cESS g /cm2 134±36 10 163±29 23 <0.05 
Stroke work gmtr/beat 82.8±46.2 10 88.7±37.8 23 ns 
E peak cm/sec 99±17 10 104±21 20 ns 
A peak cm/sec 53±12 10 58±17 20 ns 
E/A ratio  1.90±0.5 10 1.92±0.7 20 ns 
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Figure 1 
